A detailed history of Gilder Gagnon Howe & CO LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 872,974 shares of TNDM stock, worth $32.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
872,974
Previous 1,028,633 15.13%
Holding current value
$32.8 Million
Previous $41.4 Million 10.69%
% of portfolio
0.47%
Previous 0.55%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.21 - $47.3 $5.48 Million - $7.36 Million
-155,659 Reduced 15.13%
872,974 $37 Million
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $3.99 Million - $7.01 Million
131,245 Added 14.63%
1,028,633 $41.4 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $19.4 Million - $31.1 Million
879,312 Added 4864.53%
897,388 $31.8 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $258,125 - $560,898
18,076 New
18,076 $534,000
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $65,527 - $115,066
2,710 New
2,710 $66,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $5.54 Million - $8.72 Million
-126,493 Reduced 36.94%
215,980 $10.3 Million
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $21.5 Million - $49.7 Million
-403,851 Reduced 54.11%
342,473 $20.3 Million
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $2.3 Million - $3.39 Million
-22,582 Reduced 2.94%
746,324 $86.8 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $1.43 Million - $1.85 Million
-12,100 Reduced 1.55%
768,906 $116 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $894,049 - $1.24 Million
-9,561 Reduced 1.21%
781,006 $93.2 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $701,316 - $912,530
9,108 Added 1.17%
790,567 $77 Million
Q1 2021

May 17, 2021

SELL
$81.28 - $104.34 $49.5 Million - $63.5 Million
-609,058 Reduced 43.8%
781,459 $69 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $850,521 - $1.2 Million
-9,844 Reduced 0.7%
1,390,517 $133 Million
Q3 2020

Nov 16, 2020

SELL
$95.43 - $116.09 $2.07 Million - $2.52 Million
-21,696 Reduced 1.53%
1,400,361 $159 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $9.33 Million - $15.4 Million
155,311 Added 12.26%
1,422,057 $141 Million
Q1 2020

May 15, 2020

BUY
$47.37 - $90.04 $1.67 Million - $3.17 Million
35,180 Added 2.86%
1,266,746 $81.5 Million
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $32.1 Million - $43.1 Million
604,955 Added 96.54%
1,231,566 $73.4 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $483,607 - $620,704
-8,468 Reduced 1.33%
626,611 $37 Million
Q2 2019

Aug 13, 2019

BUY
$54.41 - $71.7 $5.36 Million - $7.06 Million
98,425 Added 18.34%
635,079 $41 Million
Q1 2019

May 17, 2019

BUY
$32.25 - $73.56 $13.5 Million - $30.8 Million
418,388 Added 353.77%
536,654 $34.1 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $3.25 Million - $4.64 Million
114,215 Added 2819.43%
118,266 $4.49 Million
Q3 2018

Oct 30, 2018

BUY
$21.39 - $51.17 $86,650 - $207,289
4,051 New
4,051 $174,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.41B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.